IL-12 is a proinflammatory cytokine, produced by activated antigen-presenting cells, with important regulatory activities. IL-12 p40 and p70 are produced by CNS-resident cells (mainly astrocytes and parenchymal microglia) as well as peripheral immune cells (including a portion of perivascular microglia/macrophage). However, the contribution of IL-12 produced by CNS resident cells to inflammatory demyelination is not known. Receptors for IL-12, IL-12beta1 and beta2 have different effects on the development of EAE. The mechanisms of their action in relation to IL-12 or related cytokines in EAE is not clear. IL-23, a newly discovered cytokine, has similarities and differences with IL-12 sharing its p40 and beta1 receptor chain. P40 homodimer is produced in excess and can inhibit IL-12. The contribution of IL-23 and (p40)2 in the pathogenesis of EAE is not known. Neither is it clear what role IL-12 produced in the periphery or by CNS resident cells may play in EAE relapse, especially on epitope spreading. The central hypothesis in this proposal is: cytokines with IL-12p40 subunit, IL-12, IL-23 and (p40) 2, regulate the induction, chronicity, and relapses of EAE. Specifically, we hypothesize that: 1)a) the initial immunologic damage to the CNS in EAE is mediated by the peripheral immune cells that become activated and differentiated and migrate to the CNS under the influence of IL-12p40 (in the context of IL-12 and/or IL-23), and b) IL-12p40 produced by CNS resident cells contributes to the chronicity of the disease; 2) IL-12Rbeta1and IL-12Rbeta2 have differential roles on T helper polarization resulting in differential effects in the pathogenesis of EAE; 3) IL-23 is sufficient to produce MOG-reactive Thl response and 11-12 acts as a secondary stimulus to mediate selective survival and expansion of committed MOG-reactive TH1 cells in EAE; and 4) IL-12p40 produced within the CNS contributes to epitope spreading and genesis of EAE relapse. To test these hypotheses, the following specific aims are proposed:
Aim 1 : To determine the contribution of IL-12p40 produced by peripheral immune cells and CNS resident cells in inflammatory demyelination of EAE.
Aim 2 : To characterize the differential contribution of IL-12Rbeta1 and IL-12beta2 to the pathogenesis of EAE.
Aim 3 : To differentiate the role of IL-12, IL-23 and p40 homodimer in the pathogenesis of EAE.
Aim 4 : To study the role of IL-12p40 and IL-12Rbeta2 produced or expressed on peripheral immune cells and CNS-resident cells in the pathogenesis of EAE relapse.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS046782-02
Application #
6805147
Study Section
Special Emphasis Panel (ZRG1-BDCN-2 (02))
Program Officer
Utz, Ursula
Project Start
2003-09-30
Project End
2007-05-31
Budget Start
2004-06-01
Budget End
2005-05-31
Support Year
2
Fiscal Year
2004
Total Cost
$298,300
Indirect Cost
Name
Thomas Jefferson University
Department
Neurology
Type
Schools of Medicine
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Xie, Chong; Ciric, Bogoljub; Yu, Shuo et al. (2016) IL-12R?2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis. J Neuroimmunol 291:59-69
Ding, Xiaoli; Yan, Yaping; Li, Xing et al. (2015) Silencing IFN-? binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity. J Immunol 194:4251-64
Rostami, Abdolmohamad; Ciric, Bogoljub (2013) Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination. J Neurol Sci 333:76-87
Fitzgerald, Denise C; Fonseca-Kelly, Zoƫ; Cullimore, Melissa L et al. (2013) Independent and interdependent immunoregulatory effects of IL-27, IFN-?, and IL-10 in the suppression of human Th17 cells and murine experimental autoimmune encephalomyelitis. J Immunol 190:3225-34
Zhou, Fang; Lauretti, Elisabetta; di Meco, Antonio et al. (2013) Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity. Immunobiology 218:1069-76
Li, Hongmei; Gonnella, Patricia; Safavi, Farinaz et al. (2013) Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 254:28-38
Yan, Yaping; Ding, Xiaoli; Li, Ke et al. (2012) CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes. Mol Ther 20:1338-48
Zhou, Fang; Ciric, Bogoljub; Li, Hongmei et al. (2012) IL-10 deficiency blocks the ability of LPS to regulate expression of tolerance-related molecules on dendritic cells. Eur J Immunol 42:1449-58
Li, Hongmei; Nourbakhsh, Bardia; Cullimore, Melissa et al. (2011) IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system. Eur J Immunol 41:2197-206
El-Behi, Mohamed; Ciric, Bogoljub; Dai, Hong et al. (2011) The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat Immunol 12:568-75

Showing the most recent 10 out of 17 publications